Nonsteroid antiinflammatory drugs and tamoxifen for desmoid tumors and carcinoma of the stomach (Q72780062)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6220180%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Nonsteroid antiinflammatory drugs and tamoxifen for desmoid tumors and carcinoma of the stomach (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6220180%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

31 August 2023

W. R. Waddell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220180

31 August 2023

R. E. Gerner

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220180

31 August 2023

M. P. Reich

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220180

31 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6220180

31 August 2023

publication date

1 March 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6220180%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

29 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjso.2930220314

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

https://onlinelibrary.wiley.com/doi/full/10.1002/jso.2930220314

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Journal of Surgical Oncology

31 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6220180%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6220180%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6220180%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

197-211

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6220180%20AND%20SRC:MED&resulttype=core&format=json

Indomethacin and ascorbate inhibit desmoid tumors

29 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Evidence that indomethacin reversibly inhibits cell growth in the G1 phase of the cell cycle

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

The in vivo stimulation of rat liver ornithine decarboxylase activity by dibutyryl cyclic adenosine 3',5'-monophosphate, theophylline and dexamethasone.

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

The induction of ornithine decarboxylase activity and its control in mouse skin epidermis

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Prostaglandins and skin tumor promotion: Inhibition of tumor promoter-induced ornithine decarboxylase activity in epidermis by inhibitors of prostaglandin synthesis

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Ornithine decarboxylase may function as an initiation factor for RNA polymerase I

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Cyclic AMP-mediated induction of ornithine decarboxylase in normal and neoplastic growth

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

The suppressor-cell network in cancer (first of two parts).

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Prostaglandin-Producing Suppressor Cells in Hodgkin's Disease

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Regulation of the immune response by prostaglandins

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Subversion of immune system by tumor cells and role of prostaglandins

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid(50)-L-tyrosine(50) induced in BALB/c mice by cyclophosphamide

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

A new I subregion (I-J) marked by a locus (Ia-4) controlling surface determinants on suppressor T lymphocytes

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Functional Specificity of Thymus-Dependent Lymphocytes

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

In vivo effects of anti-Ia alloantisera. I. Elimination of specific suppression by in vivo administration of antisera specific for I-J controlled determinants

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. IV. Special subregion assignment of the gene(s) that codes for the suppressive T-cell factor in the H-2 histocompatibility complex

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

31 August 2023

356a

Osband

1980

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

31 August 2023

111

394

Plaut

1973

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Characterization of the human blood lymphocytes that produce a histamine-induced suppressor factor (HSF)

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Regulation of antibody response by cells expressing histamine receptors

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Cimetidine reduction of tumour formation in mice

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Successful tumour immunotherapy with cimetidine in mice

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Immunosuppressive factor(s) specific for L-glutamic acid(50)-L- tyrosine(50) (GT). II. Presence of I-J determinants on the GT-suppressive factor

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Treatment of Intra-abdominal and Abdominal Wall Desmoid Tumors With Drugs That Affect the Metabolism of Cyclic 3', 5'-Adenosine Monophosphate

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

British Journal of Pharmacology

31 August 2023

469

Pugh

1975

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Production of prostaglandins by the pseudopregnant rat uterus, in vitro, and the effect of tamoxifen with the identification of 6-keto-prostaglandin F1alpha as a major product

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

The effect of tamoxifen on the in vitro production of prostaglandins F by the guinea pig uterine tissue

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Induction of uterine ornithine decarboxylase (ODC) by antiestrogens. Inhibition of estradiol-mediated induction of ODC: a possible mechanism of action of antiestrogens

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Cancer chemotherapy reports

31 August 2023

163

Mantel

1966

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Cyclic AMP-mediated induction of ornithine decarboxylase of glioma and neuroblastoma cells

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

The involvement of cyclic AMP-dependent protein kinase(s) in the induction of ornithine decarboxylase in the regenerating rat liver and in the adrenal gland after unilateral adrenalectomy

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

31 August 2023

108

1526

Henney

1972

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

31 August 2023

Cancer Treatment Reports

1323

Pollard

1980

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Prostaglandins: fine tuning the immune system?

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Antigen stimulation of prostaglandin synthesis and control of immune responses.

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Indomethacin-responsive mononuclear cell dysfunction in Hodgkins disease

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Control of mitogen-induced transformation: Characterization of a splenic suppressor cell and its mode of action

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in mice

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

The I-J subregion codes for determinants on suppressor factor(s) which limit the contact sensitivity response to picryl chloride

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

31 August 2023

116

791

Fujimoto

1976

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

31 August 2023

116

800

Fujimoto

1976

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

Cimetidine as an immunomodulator: chronic mucocutaneous candidiasis as a model

31 August 2023

1 reference

https://api.crossref.org/works/10.1002/JSO.2930220314

31 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6220180%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6220180%20AND%20SRC:MED&resulttype=core&format=json